Diabetes Therapy
Addition of thiazolidinedione to sulfonylurea therapy lowers myocardial infarction risk
Published in Obesity and Diabetes Week, May 8th, 2006
"Type 2 diabetes mellitus and insulin resistance are associated with an increased risk of myocardial infarction (MI). Although differences exist in insulin sensitization among oral hypoglycemic drugs, it is unclear whether these differences translate into a differential risk of MI and whether differences exist among these drugs. We conducted a case-control study of first MI in a 5-county area during a. 56-month period," scientists in the United States report.
"The patients were those with type 2 diabetes mellitus hospitalized with a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diet & Nutrition
Orexigenic peptides are overexpressed after early life exposure to fat-rich diet - Obesity Complications
Body mass index contributes to both baseline and weight loss white blood cell count - Obesity Pathogenesis
GABAA receptor antagonists prevent defects in leptin, insulin and amylin actions in obese - Obesity Pathogenesis
Plasma antioxidant capacity values are impaired in morbidly obese patients - Obesity Therapy
Increased serum amyloid A levels in morbid obesity decrease after gastric bypass - Angiology
New data from the People's Republic of China, United States and Germany lluminates research in angiology - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
